Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
FY2027 revenue of $45.98 billion and adjusted diluted EPS of $9.17 are dated expectations, not reported results.
FY2027 adjusted diluted EPS falls below $8.78.
Strong Buy. The shares were $184.73 on 2026-09-08, below Fair value of $248.88. Size the position with care because FY2025 debt of $48.84 billion exceeded cash of $4.87 billion, while Customer One represented 12% of revenue. Weaker cash generation would leave less room for debt service, dividends, and reinvestment. Upside remains if FY2027 revenue and adjusted EPS meet dated expectations and reported profit keeps turning into operating cash.1356
The report-date price offers 34.73% upside to Fair value. Potential value is $351.51, but it requires stronger regional growth and sustained cash generation.3
The view changes if FY2027 adjusted diluted EPS falls below $8.78. That would break the visible earnings anchor and weaken the longer growth path.1
The clearest reason the stock can outperform is continued sales growth with strong conversion of profit into cash. FY2025 free cash flow was $10.66 billion.4
The constructive cycle is demand-led: Europe remains positive while faster-growing regions add sales. Sseacismea already generated $12.05 billion in FY2025 revenue.6
Strong Buy because the report-date price remains below Fair value while FY2027 estimates and cash generation support continued growth.5
The constructive cycle is demand-led and conditional. Europe must remain positive while regions outside Europe expand. Sseacismea's $12.05 billion of FY2025 revenue provides a meaningful base, but does not prove faster future growth.6
Strong Buy because the report-date price remains below Fair value, while FY2027 revenue and adjusted EPS delivery must confirm that profit growth and cash generation are durable.15
PMI operates globally with manufacturing and sales facilities in various locations around the world and is exposed to risks such as changes in foreign currency exchange rates and interest rates. The primary currencies to which PMI is exposed include the Euro, Indian rupee, Indonesian rupiah, Japanese yen, Russian ruble and Swiss franc. Collaborative Culture. However, the company typicallies experience higher SFP adult user growth in the first half of each year versus the second half of each year due to seasonal influences. These net revenue amounts consist of the sale of its cigarettes and other tobacco products that are combusted.
Other tobacco products primarily include roll-your-own and make-your-own cigarettes, pipe tobacco, cigars and cigarillos and do not include smoke-free products. The updated organizational structure is designed to enhance its agility and to support its journey to become a smoke-free company under the leadership of Jacek Olczak, Group CEO of PMI.
Europe weakness combined with customer impairment could overwhelm growth elsewhere and pressure both sales and margins.
Customer switching, distribution control, pricing power, brand strength, scale, and regulatory positioning are the relevant protections. The cited record establishes regional and customer concentration, not durable barriers that prevent customers or competitors from changing behavior.
The peer set is only a valuation cross-check. MO is the closest tobacco reference, while COST, WMT, and MDLZ provide broader consumer context; their growth, margins, and multiples differ widely.
FY2025 operating income was $14.89 billion, and operating cash flow reached $12.23 billion. These outcomes show attractive present economics, but they do not establish customer lock-in, protected distribution, or lasting pricing power.
The highlighted cell is Fair value when every assumption sits at its base level ($248.88). Each row and column shows what Fair value becomes when one assumption moves.
Free cash flow to the firm stays positive in the first projected year at $12.0B after modeled capex of $1.6B, with terminal value at 75.6% of . A sudden drop in free cash flow is not projected unless capital spending relative to , reinvestment, or resets materially.
After a beat, compare Europe and the region covering South and Southeast Asia, the Commonwealth of Independent States, the Middle East, and Africa with their prior periods. If both increase, the near-term case strengthens; gains confined to one region would leave growth concentrated.
The industry benchmark dated 2026-09-01 showed capex at -0.9% of revenue and 0.71 times depreciation.
The constructive cycle is demand-led and conditional. Europe must remain positive while regions outside Europe expand. Sseacismea's $12.05 billion of FY2025 revenue provides a meaningful base, but does not prove faster future growth.
A weak cycle would combine Europe stagnation with customer pressure, reducing sales before costs adjust. Europe produced $17.11 billion of FY2025 revenue.
Investor-specific; no fixed portfolio percentage is evidence-backed. Build exposure in stages rather than at a single price. Although the report-date price is below Fair value, debt materially exceeded cash in FY2025, and Customer One represented 12% of revenue. If future operating cash weakens, debt service could leave less cash for dividends and reinvestment.356
Maintain the Strong Buy and build exposure in stages rather than at a single price. If FY2027 adjusted diluted EPS falls below the $8.78 analyst-consensus low as of 2026-09-09, or Customer One is lost or repriced, reassess sales, profit and cash assumptions. Keep each tranche small enough that a breach of either trigger does not force a sale.
FY2027 revenue and adjusted EPS estimates support continued mature growth.1
FY2025 operating cash flow and free cash flow support distributions, although leverage limits flexibility.45
Use staged purchases because Europe, customer concentration, , and conflicting earnings-quality evidence can amplify an operating miss.
At $184.73 on 2026-09-08, the shares stand below Fair value of $248.88.3
The valuation case requires FY2027 revenue and adjusted EPS near analyst forecasts as of 2026-09-09. Europe revenue growth must remain positive, Customer One must remain stable, and reported profit must continue turning into operating cash.
Capture your own thesis, position size, and follow-up questions. Stays on this device, only you can see it.
The records this analysis drew on, as they stood when it was run.
At each annual update, test whether Europe revenue contracts and whether Customer One is lost or repriced. The FY2025 disclosures establish exposure levels, not deterioration. If operating cash also weakens, debt service could claim more cash and leave less for dividends and reinvestment.
Adjusted diluted EPS below $8.78 breaks the visible growth anchor.
Cash below $0.80 per $1 of profit challenges earnings durability.
Cost of equity above 9.06% lowers the value of future earnings.
The five developments that would weaken our investment case.
A reported FY2027 result below the analyst-consensus low as of 2026-09-09 would reduce expected profit and weaken the near-term earnings anchor supporting the longer growth path.
Current:$9.17 mean; $8.78 low
Alert ifBelow $8.78 in FY2027
Sustained Europe weakness would reduce company sales and could pressure profit and cash. Check each annual regional sales disclosure to see whether weakness persists or other regions offset it.
Current:$17.11 billion revenue in FY2025
Alert ifAt or below 0% for two fiscal years
Customer impairment is a plausible, high-severity risk. Check each annual concentration disclosure and contract update; lost volume or lower pricing would hit sales before costs adjust, reducing profit and cash.
Current:12% of FY2025 revenue
Alert ifAny disclosed loss or repricing
FY2025 debt of $48.84 billion versus $4.87 billion of cash leaves less flexibility if operating cash weakens. More cash could be diverted to debt service, limiting dividends and reinvestment.
Current:$1.08 in FY2025
Alert if$0.80 or less for a trailing fiscal year
A higher required return would reduce what investors pay for unchanged future earnings. Recalculate the cost of equity at each update to test whether valuation pressure is rising.
Current:7.06% on 2026-09-09
Alert ifAbove 9.06% within 12 months
Each lens answers a different valuation question. Only included lenses set Fair value; floors and diagnostics provide context.
Project SBC-adjusted EPS, discount each year's earnings at cost of equity, then add a Gordon-growth terminal value.
Limitation: Terminal value is 77% of this model's value, above the 60% level at which the methodology flags concentration; the value leans on the years beyond the explicit forecast.
Project EPS through the explicit advantage period, fade growth as competition catches up, and discount the full stream at cost of equity.
Limitation: Terminal value is 82.7% of this model's value, above the 60% level at which the methodology flags concentration; the value leans on the years beyond the explicit forecast.
Apply a terminal P/E to the dated forward EPS path, then discount that future share value back to the analysis date.
Convert the revenue and margin path into after-tax free cash flow, discount the annual per-share amounts and at , then adjust for signed per current share.
Add depreciation to net income, subtract maintenance capex, divide by diluted shares, and apply a normalized valuation multiple.
Multiply the peer median PEG by this stock's forecast growth to derive an implied forward P/E, then apply it to forward EPS.
Solve for the growth rate that makes the model value equal the report-date share price.
The base path requires FY2027 revenue and adjusted EPS near analyst forecasts as of 2026-09-09. Each annual update should test whether Europe revenue growth remains positive and reported profit keeps turning into operating cash. Europe stagnation or weaker cash generation would disconfirm the path.156
The path gains support if FY2027 revenue and adjusted EPS exceed dated expectations while free cash flow remains strong. Positive Europe growth must also continue; Europe stagnation would disconfirm the path.146
Delivery near the dated FY2027 revenue and adjusted-EPS estimates would preserve the near-term thesis, but would not prove that later regional growth is durable.
After a miss, compare Europe revenue and the disclosed Customer One share with their prior-period figures. Use those disclosures to distinguish a regional or customer setback from a miss not explained by either exposure.
FY2025 cash from operations exceeded net income. Later filings should confirm that reported profit keeps turning into cash before investors treat the earnings as durable.5
A shortfall would weaken expected profit growth.1
Sales delivery supports the earnings path.1
Weakness in the largest region could offset growth elsewhere.6
Loss or repricing would reduce sales or margins.6
Weak conversion would reduce debt and distribution capacity.
| $31.41B |
| $31.76B |
| $35.17B |
| $37.88B |
| $40.65B |
| +6.7% |
| Gross profit | $21.38B | $20.36B | $22.28B | $24.55B | $27.28B | +6.3% |
| Operating income | $12.98B | $12.25B | $11.56B | $13.40B | $14.89B | +3.5% |
| Net income | $9.11B | $9.05B | $7.81B | $7.06B | $11.35B | +5.6% |
| EPS (diluted) | $5.83 | $5.81 | $5.02 | $4.52 | $7.26 | +5.6% |
| EBITDA | $2.93B | $13.48B | $13.37B | $15.75B | $17.46B | +56.3% |
| R&D | $617.0M | $642.0M | $709.0M | $759.0M | $756.0M | +5.2% |
| SG&A | $8.42B | $8.11B | $10.06B | $11.15B | $11.75B | +8.7% |
FY2025 operating cash flow exceeded net income, and free cash flow remained positive after $1.57 billion of capital spending. One statistical review of reported earnings conflicts with another reading, so later filings must confirm that cash generation is durable.5
Debt reduction would improve flexibility because FY2025 debt of $48.84 billion exceeded cash of $4.87 billion. September 2026 shares outstanding and FY2025 diluted-average shares were close, but their different share bases do not establish a dilution trend.
The dated evidence supports an assessment of operating profit and cash generation, but it does not establish a comparable multi-period return-on-invested-capital trend.
The comparison is undetermined. WACC was 6.6344% on 2026-09-09, but no matching dated ROIC trajectory is asserted.
FY2025 operating cash flow was $12.23 billion and free cash flow was $10.66 billion.
Cash can support distributions and debt service if profit continues converting into cash.
FY2025 debt was $48.84 billion versus $4.87 billion of cash.
An operating miss could redirect cash from distributions or reinvestment toward financing needs.
| Revenue | $40,648,000,000 |
|---|---|
| Cost of revenue | $13,366,000,000 |
| Gross profit | $27,282,000,000 |
| Operating expenses | $12,390,000,000 |
| Operating income | $14,892,000,000 |
| Non-operating items and tax | -$3,544,000,000 |
| Net income | $11,348,000,000 |
| Total assets | $69,185,000,000 |
|---|---|
| Cash | $4,872,000,000 |
| Current assets | $24,363,000,000 |
| Total liabilities | $77,213,000,000 |
| Current liabilities | $25,427,000,000 |
| Shareholder deficit | $8,028,000,000 |
| Net income | $11,348,000,000 |
|---|---|
| Operating inflow | $13,344,000,000 |
| Depreciation and amortization | $1,996,000,000 |
| Operating cash flow | $12,233,000,000 |
| Operating outflow | $1,111,000,000 |
| Cash available | $16,991,000,000 |
| Beginning cash | $4,254,000,000 |
| Exchange-rate effect | $504,000,000 |
| Investing outflow | $3,967,000,000 |
| Capex | $1,569,000,000 |
| Other investing activities | $2,398,000,000 |
| Financing outflow | $8,132,000,000 |
| Net debt issuance | $1,706,000,000 |
| Dividends paid | $8,624,000,000 |
| Other financing activities | $1,214,000,000 |
| Ending cash | $4,892,000,000 |
| Investing cash flow | -$3,967,000,000 |
| Financing cash flow | -$8,132,000,000 |
Source: SEC EDGAR · Filed 2026-02-06 · SEC EDGAR
| Revenue by operating segment | Revenue | Share | YoY |
|---|---|---|---|
| Europe | $17.1B | 42.1% | 9.1% |
| SSEACISMEA | $12.1B | 29.6% | 7% |
| EAAUPMIGTR | $6.6B | 16.3% | 3.7% |
| Americas | $4.9B | 11.9% | 7.1% |
Point-in-time financial data used in the 2026-09-09 analysis.
| Period | Revenue | EBITDA | Net income | Operating cash flow | Free cash flow | Capex | Depreciation and amortization | Stock-based compensation | Share repurchases | Dividends paid | Net debt issuance | Investing cash flow | Financing cash flow | Beginning cash | Ending cash | Cash and investments | Total debt | Operating margin | ROIC | WACC | ROIC − WACC spread |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | $26.7B | $11.7B | $7B | $8.1B | $6.9B | $1.2B | $743M | $153M | $0 | $6.4B | — | -$834M | -$5.4B | — | $4.3B | $4.2B | $29.1B | 40.9% | — | 5.1% | — |
| 2017-12-31 | $28.7B | $12.5B | $6B | $8.9B | $7.4B | $1.5B | $875M | $148M | $0 | $6.5B | — | -$3.1B | -$2.8B | $4.3B | $8.5B | $8.4B | $34.3B | 40.3% | — | 5.0% | — |
| 2018-12-31 | $29.6B | $12.5B | $7.9B | $9.5B | $8B | $1.4B | $989M | $138M | — | $6.9B | — | -$998M | -$9.7B | $8.5B | $6.6B | $6.6B | $31.8B | 38.4% | — | 4.9% | — |
| 2019-12-31 | $29.8B | $11.6B | $7.2B | $10.1B | $9.2B | $852M | $964M | $371M | $0 | $7.2B | — | -$1.8B | -$8.1B | $6.6B | $6.9B | $6.9B | $31B | 35.3% | — | 4.4% | — |
| 2020-12-31 | $28.7B | $12.7B | $8.1B | $9.8B | $9.2B | $602M | $981M | -$14M | $0 | $7.4B | — | -$1.2B | -$8.5B | $6.9B | $7.3B | $12.1B | $31.5B | 40.7% | — | 3.0% | — |
| 2021-12-31 | $31.4B | $2.9B | $9.1B | $12B | $11.2B | $748M | $998M | -$22M | $775M | $7.6B | — | -$2.4B | -$12B | $7.3B | $4.5B | $4.5B | $25B | 41.3% | — | 3.9% | — |
| 2022-12-31 | $31.8B | $13.5B | $9B | $10.8B | $9.7B | $1.1B | $1.1B | $183M | $209M | $7.8B | $14.2B | -$15.7B | $3.8B | $4.5B | $3.2B | $3.2B | $43.1B | 38.6% | — | 5.9% | — |
| 2023-12-31 | $35.2B | $13.4B | $7.8B | $9.2B | $7.9B | $1.3B | $1.4B | $212M | $0 | $8B | $3.7B | -$3.6B | -$5.6B | $3.2B | $3.1B | $3.1B | $47.9B | 32.9% | — | 5.8% | — |
| 2024-12-31 | $37.9B | $15.7B | $7.1B | $12.2B | $10.8B | $1.4B | $1.8B | — | $0 | $8.2B | -$1.6B | -$1.1B | -$9.5B | $3.1B | $4.3B | $4.2B | $45.7B | 35.4% | — | 6.4% | — |
| 2025-12-31 | $40.6B | $17.5B | $11.3B | $12.2B | $10.7B | $1.6B | $2B | — | — | $8.6B | $1.7B | -$4B | -$8.1B | $4.3B | $4.9B | $4.9B | $48.8B | 36.6% | — | 6.1% | — |
Philip Morris International Inc. (PM) trades at 20.4x forward earnings against a peer median of 25.6x. Its EV/EBITDA of 18.5x compares with a peer median of 18.5x. The comparison uses 4 peers: Costco Wholesale Corporation, Altria Group Inc., Walmart Inc. and Mondelez International Inc., as of 2026-09-08 to 2026-09-09.
| Impact |
|---|
| Note |
|---|
| Regional mix diversification | positive | Meaningful revenue outside Europe can partly offset mature-region weakness. |
| Europe dependence | negative | Two consecutive years of non-positive Europe growth would lower consolidated growth and profit expectations. |
FY2025 capex was $1.57 billion. Continued growth without sharply higher capital needs would support cash generation, although the long-run reinvestment requirement remains uncertain.5
| Level | Action | Why |
|---|
| $184.73 or lower | Act on the Strong Buy by building the position in stages at this level or lower, reviewing valuation before each tranche. | This is at or below the report-date price from 2026-09-08 and remains below Fair value. |
Not every cited input appears here: internal calculations and intermediate model outputs have no external record, and some citations could not be matched to one.
Limitation: Terminal value is 75.6% of this model's value, above the 60% level at which the methodology flags concentration; the value leans on the years beyond the explicit forecast.
Value each distinct segment, subtract corporate overhead and net debt, add probability-weighted optionality, and divide by diluted shares.
Discount the explicit dividend path and its Gordon-growth terminal value at cost of equity.
| $15.92B |
| $16.86B |
| $17.73B |
| $18.58B |
| $19.42B |
| $20.23B |
| $21.04B |
| $21.84B |
| $22.65B |
| $23.47B |
| NOPAT | $12.17B | $12.88B | $13.55B | $14.20B | $14.84B | $15.46B | $16.08B | $16.69B | $17.31B | $17.94B |
| Residual cash after reinvestment policy | $12.17B | $12.88B | $13.55B | $14.20B | $14.84B | $15.46B | $16.08B | $16.69B | $17.31B | $17.94B |
| Revenue growth | 6.8% | 5.9% | 5.2% | 4.8% | 4.5% | 4.2% | 4.0% | 3.8% | 3.7% | 3.6% |
| Operating margin | 36.7% | 36.7% | 36.7% | 36.7% | 36.7% | 36.7% | 36.7% | 36.7% | 36.7% | 36.7% |
| Tax rate | 23.6% | 23.6% | 23.6% | 23.6% | 23.6% | 23.6% | 23.6% | 23.6% | 23.6% | 23.6% |
| Reinvestment rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Terminal growth | 3.6% | 3.6% | 3.6% | 3.6% | 3.6% | 3.6% | 3.6% | 3.6% | 3.6% | 3.6% |
| MO |
| Altria Group Inc. |
| 11.6x |
| 5.6x |
| 8.6x |
| — |
| 61.5% |
| WMT | Walmart Inc. | 32.8x | 1.1x | 20.7x | 22.3% | 3.5% |
| MDLZ | Mondelez International Inc. | 18.3x | 2.0x | 16.3x | 13.3% | 22.0% |
